Françoise Bex
University of Texas Southwestern Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Françoise Bex.
Molecular and Cellular Biology | 1998
Françoise Bex; Min-Jean Yin; Arsène Burny; Richard B. Gaynor
ABSTRACT The human T-cell leukemia virus type 1 Tax protein transforms human T lymphocytes, which can lead to the development of adult T-cell leukemia. Tax transformation is related to its ability to activate gene expression via the ATF/CREB and the NF-κB pathways. Transcriptional activation of these pathways is mediated by the actions of the related coactivators CREB binding protein (CBP) and p300. In this study, immunocytochemistry and confocal microscopy were used to localize CBP and p300 in cells expressing wild-type Tax or Tax mutants that are able to selectively activate gene expression from either the NF-κB or ATF/CREB pathway. Wild-type Tax colocalized with both CBP and p300 in nuclear bodies which also contained ATF-1 and the RelA subunit of NF-κB. However, a Tax mutant that selectively activates gene expression from only the ATF/CREB pathway colocalized with CBP but not p300, while a Tax mutant that selectively activates gene expression from only the NF-κB pathway colocalized with p300 but not CBP. In vitro and in vivo protein interaction studies indicated that the integrity of two independent domains of Tax delineated by these mutants was involved in the direct interaction of Tax with either CBP or p300. These studies are consistent with a model in which activation of either the NF-κB or the ATF/CREB pathway by specific Tax mutants is mediated by distinct interactions with related coactivator proteins.
The EMBO Journal | 1991
Marie Horth; Bart Lambrecht; Marinee Chuah Lay Khim; Françoise Bex; Clotilde Thiriart; Jean Marie Ruysschaert; Arsène Burny; Robert Brasseur
The fusion domain of simian immunodeficiency virus (SIV) envelope glycoproteins is a hydrophobic region located at the amino‐terminal extremity of the transmembrane protein (gp32). Assuming an alpha helical structure for the SIV fusogenic domain of gp32 in a lipid environment, theoretical studies have predicted that the fusion peptide would insert obliquely in the lipid bilayer. This oblique insertion could be an initial step of the fusion process by disorganizing locally the structure of the lipid bilayer. We have tested this hypothesis by selectively mutagenizing the SIV gp160 expressed via a vaccinia virus vector, to alter the theoretical angle of insertion of the fusion peptide. The fusogenic activity of the wild‐type and mutant glycoproteins was tested after infection of T4 lymphocytic cell lines by the recombinant vaccinia virus, and measure of syncytia formation. Mutations that modified the oblique orientation reduced the fusogenic activity. In contrast, mutations that conserve the oblique orientation did not alter the fusogenic properties. Our results support the hypothesis that oblique orientation is important for fusogenic activity.
Vaccine | 2001
Charlotta Nilsson; Barbro Mäkitalo; Peter Berglund; Françoise Bex; Peter Liljeström; Gerd Sutter; Volker Erfle; Peter ten Haaft; Jonathan L. Heeney; Gunnel Biberfeld; Rigmor Thorstensson
The immunogenicity of two vector-based vaccines, either given alone or in a prime-boost regimen, was investigated. Cynomolgus macaques were immunised with modified vaccinia virus Ankara (MVA) expressing simian immunodeficiency virus (SIV)macJ5 env, gag-pol, nef, rev, and tat genes (MVA-SIVmac) or primed with a Semliki forest virus (SFV) vaccine expressing the same genes (SFV-SIVmac) and boosted with MVA-SIVmac. Generally, antibody responses, T-cell proliferative responses and cytotoxic T-cell responses remained low or undetectable in vaccinees receiving MVA-SIVmac or SFV-SIVmac alone. In contrast, monkeys who first received SFV-SIVmac twice and then were boosted with MVA-SIVmac showed increased antibody responses as well as high T-cell proliferative responses. Three of these vaccinees had cytotoxic T-lymphocytes directed against three or four of the gene products. No evidence of protection was seen against an intrarectal heterologous SIVsm challenge given 3 months after the last immunisation. The study demonstrates a prime-boost strategy that efficiently induces both humoral and cellular immune responses.
Journal of Virology | 2001
Joris Hemelaar; Françoise Bex; Bruce L. Booth; Vincenzo Cerundolo; Andrew J. McMichael; Susan Daenke
ABSTRACT The human T-cell leukemia virus type 1 (HTLV-1) Tax protein activates the HTLV-1 long terminal repeat and key regulatory proteins involved in inflammation, activation, and proliferation and may induce cell transformation. Tax is also the immunodominant target antigen for cytotoxic T cells in HTLV-1 infection. We found that Tax bound to assembled nuclear proteasomes, but Tax could not be detected in the cytoplasm. Confocal microscopy revealed a partial colocalization of Tax with nuclear proteasomes. As Tax translocated into the nucleus very quickly after synthesis, this process probably takes place prior to and independent of proteasome association. Tax mutants revealed that both the Tax N and C termini play a role in proteasome binding. We also found that proteasomes from Tax-transfected cells had enhanced proteolytic activity on prototypic peptide substrates. This effect was not due to the induction of the LMP2 and LMP7 proteasome subunits. Furthermore, Tax appeared to be a long-lived protein, with a half-life of around 15 h. These data suggest that the association of Tax with the proteasome and the enhanced proteolytic activity do not target Tax for rapid degradation and may not determine its immunodominance.
Journal of Virology | 1996
Sally P. Mossman; Françoise Bex; Peter Berglund; James Arthos; Shawn P. O'Neil; Deborah Riley; Donald H. Maul; Claudine Bruck; Patricia M. Momin; Arsène Burny; Patricia N. Fultz; John Mullins; Peter Liljeström; Edward A. Hoover
Methods | 1998
Françoise Bex; Richard B. Gaynor
Journal of Virology | 1994
Z R Israel; P F Edmonson; Donald H. Maul; Shawn P. O'Neil; S P Mossman; Clotilde Thiriart; Luc Fabry; O Van Opstal; Claudine Bruck; Françoise Bex
Encyclopedia Of Molecular Medicine | 2002
Françoise Bex; Arsène Burny; A. Van den Broeke; C. Van Lint
Abstract of the Meeting « Cell signaling, transcription and translation as therapeutic targets » | 2002
Emmanuelle Adam; Vincent Quivy; Françoise Bex; Sonia Schoonbroodt; Arsène Burny; Vincent Bours; J. Piette; Carine Van Lint
Abstract of the 1999 International Symposium on HIV, Leukemia, and Opportunistic Cancers | 1999
Françoise Bex; Arsène Burny; Anne Van den Broeke; Carine Van Lint